Scientific Session Abstracts

Sheridan World Resorts, Orlando, FL
July 27, 2005

• Necdin and MAGEL2: Candidate Genes for Prader-Willi Syndrome

• Biomarkers for Pediatric Type 2 Diabetes in Subjects with Prader-Willi Syndrome

• Psychiatric Resilience among Individuals with Prader-Willi Syndrome and Presumed Maternal Uniparental Disomy
  Warranting Further Genetic Testing

• Autistic Phenotype and Hyperphagia in an Adolescent Male with Paternal Microdeletion of GABRB3

• Psychiatric Phenomenology of Mood Activation in Prader-Willi Syndrome

• Psychopathologic Disorder in Prader-Willi Syndrome

• Cognitive and Behavioral Findings in Prader-Willi Syndrome and Early-Onset Morbid Obesity

• The Use of Psychotropic Medications in Prader-Willi Syndrome

• Sleep in Prader-Willi Syndrome: Sleepiness and Sleep Disordered Breathing- Relationship to Genotype, Growth
  Hormone Therapy and Body Composition

• Stabilization of Scoliosis in Subjects with Prader-Willi Syndrome Treated with GH-therapy

• Prader-Willi Syndrome Association (USA) Database Collection Uncover Areas of Needed Research

• Causes of Death in Prader-Willi Syndrome Utilizing the Prader-Willi Syndrome Association USA Bereavement
  Program: Documentation of a Functional Infrastructure

• Assessment of Energy Expenditure in Prader-Willi Syndrome: Comparison with Obese Subjects

• Growth Hormone Effects in Infants and Toddlers with Prader-Willi Syndrome: Does Early Intervention Make a
  Difference?

• The Existence and Experience of Body Image in Individuals with Prader-Willi Syndrome

• Lack of Satiety: It’s Not Just About Food